Home » Topics » BioWorld Science, Biomarkers

BioWorld Science, Biomarkers
RSS

Plexin D1-positive extracellular vesicles as potential biomarker of polymyositis and dermatomyositis

Nov. 17, 2021

IL-36-gamma is a marker of enthesitis-related arthritis

Nov. 17, 2021

IL-40 is upregulated in rheumatoid arthritis and decreases following depletion therapy

Nov. 16, 2021

ITIH4 is a marker for early diagnosis of gastric cancer

Nov. 12, 2021

Circulating levels of galectin-1 associated with lower kidney function

Nov. 12, 2021

Researchers identify markers of adrenomyeloneuropathy severity

Nov. 10, 2021

Urinary follistatin useful to monitor AKI severity

Nov. 8, 2021

SLC6A14 polymorphism tied to cystic fibrosis severity

Nov. 4, 2021

LncRNA LINC00978 is a potential diagnostic marker of colorectal cancer

Nov. 3, 2021

High blood LPE(20:4) levels tied to migraine

Nov. 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...